ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

Market Movers(Regular)

View all
NasdaqNYSEAMEXOTCTSXEuronextLSE

NASDAQ Market Status

Advancing
2,424(61.92%)
Declining
1,446(36.93%)
Unchanged
45(1.15%)
  • % Gainers
  • % Losers
  • Most Active
TickerNamePriceChangeChange %Volume
AVTX LogoAVTXAvalo Therapeutics Inc22.979918.23383.79%11,896,544
XLO LogoXLOXilio Therapeutics Inc1.641.00156.65%19,291,196
BDRX LogoBDRXBiodexa Pharmaceuticals PLC1.65930.800393.17%53,718,177
OTRK LogoOTRKOntrak Inc0.930.33556.30%7,664,458
AKAN LogoAKANAkanda Corporation0.2377630.0728644.19%46,714,354
PIK LogoPIKKidpik Corporation4.641.3741.90%7,723,819
BCG LogoBCGBinah Capital Group Inc13.003.5036.84%309,950
NXL LogoNXLNexalin Technologies Inc1.0150.23530.13%446,943
HUBCW LogoHUBCWHub Cyber Security Ltd0.01790.004129.71%600
HUT LogoHUTHut 8 Corporation11.751.8919.17%5,376,262
CERO LogoCEROCERo Therapeutics Holdings Inc1.92990.299918.40%275,348
PMEC LogoPMECPrimech Holdings Ltd1.98-1.90-48.97%1,219,549
NBSTW LogoNBSTWNewbury Street Acquisition Corporation0.042279-0.02622-38.28%1,750
GMDA LogoGMDAGamida Cell Ltd0.043251-0.01595-26.94%30,091,388
UGRO LogoUGROUrban Gro Inc1.3799-0.4351-23.97%265,951
KOD LogoKODKodiak Sciences Inc5.74-1.71-22.95%495,139
TNXP LogoTNXPTonix Pharmaceuticals Holding Corporation0.2623-0.0646-19.76%5,467,277
DTST LogoDTSTData Storage Corporation6.1689-1.47-19.26%338,080
MLKN LogoMLKNMillerKnoll Inc25.15-5.38-17.62%1,089,160
MVLA LogoMVLAMovella Holdings Inc0.0626-0.0129-17.09%975,747
QH LogoQHQuhuo Ltd0.485-0.0876-15.30%633,668
ABTS LogoABTSAbits Group Ltd0.6801-0.1169-14.67%315,809
NKLA LogoNKLANikola Corporation1.020.110912.20%63,931,701
BDRX LogoBDRXBiodexa Pharmaceuticals PLC1.65930.800393.17%53,718,177
AKAN LogoAKANAkanda Corporation0.2377630.0728644.19%46,714,354
GMDA LogoGMDAGamida Cell Ltd0.043251-0.01595-26.94%30,091,388
CISS LogoCISSC3is Inc0.0345-0.0037-9.69%28,857,945
AKBA LogoAKBAAkebia Therapeutics Inc2.250.010.45%27,893,272
KTRA LogoKTRAKintara Therapeutics Inc0.10110.011612.96%24,269,927
TSLA LogoTSLATesla Inc176.776-3.05-1.70%23,214,222
MARA LogoMARAMarathon Digital Holdings Inc23.761.697.66%21,718,916
SQQQ LogoSQQQProShares UltraPro Short QQQ10.44030.04030.39%21,497,478
XLO LogoXLOXilio Therapeutics Inc1.641.00156.65%19,293,365
TradesView all

Big Movers

11:00
Business Wire

Gilead Sciences, Inc. (Nasdaq: GILD) and Xilio Therapeutics, Inc. (Nasdaq: XLO) today announced an exclusive license agreement to develop and commercialize Xilio’s Phase 1 tumor-activated IL-12 program, XTX301.

12:30
PR Newswire (US)

SINGAPORE, March 28, 2024 /PRNewswire/ -- Primech Holdings Limited (Nasdaq: PMEC) ("Primech" or the "Company"), an established technology-driven facilities services provider in the public and private sectors operating mainly in Singapore, provides a financial and corporate update coincident with the filing of the Company's financial results for the six months ended September 30, 2023. These financial results are for periods prior to the Company's initial public offering ("IPO") in October of 2023.

12:02
Business Wire

Kidpik Corp. (NASDAQ: PIK) ("kidpik” or the "Company"), an online clothing subscription-based e-commerce company, today announced that the Company received written notification from the Listing Qualification Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that is has regained full compliance with the Minimum Bid Price Requirement.

10:30
PR Newswire (US)

Three clinical programs present diversified opportunities in and outside the existing anti-VEGF market and are being progressed toward Phase 3 value inflection points  New Phase 3 GLOW2 study of tarcocimab in diabetic retinopathy actively recruiting  Phase 1b study of KSI-101 planned for 2Q2024 with the goal of initiating dual pivotal studies in 2024  New Phase 3 DAYBREAK study in wet AMD to include KSI-501 and tarcocimab investigational groups versus aflibercept targeted to start recruitment mid-2024 following completion of FDA discussions  Investor day to be scheduled after on-going regulatory interactions completedPALO ALTO, Calif., March 28, 2024 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), today reported business highlights and ...

Ticker Buzz Cloud
What is the Buzz Cloud?
  • The Buzz Cloud keeps track of how often tickers are mentioned to indicate the "level of buzz".
  • The larger the text, the more often the ticker is mentioned by the community.
  • You can use this page to spot trading opportunities based on the increase or decrease in the level of buzz.

Unlock more advanced trading tools

Join ADVFN today

Top Cryptocurrencies

View All Cryptos
Crypto Market Status
Advancing
9121(34%)
Declining
2719(10%)
Unchanged
14508(56%)
Ticker Name Price Change Change % Market Cap Volume
BTCBitcoin71,409.151,945.832.80%1.4T7,581,295,332
ETHEthereum3,602.28102.312.92%433.07B3,898,383,195
USDTTether USD1.000.000560.06%97.84B1,033,665,059
BNBBinance Coin586.0011.872.07%92.43B514,650,269
SOLSolana188.172.111.13%82.65B1,683,514,224
STETHstETH3,587.15122.723.54%35.14B13,012,474
XRPRipple0.62330.01171.91%33.96B562,150,306
DOGEDogecoin0.219290.0292515.39%31.49B2,845,453,404
USDCUSD Coin1.000.000.00%28.07B1,433,361,766
ADACardano0.65650.00891.37%23.03B191,258,307

Economic Calendar

This week's major US economic reports, Fed Speakers, indicators and market-moving events.
View full calendar